Citation, commencement and extent

1. —(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment No. 2) (England, Wales and Scotland) Order 2013 and shall come into force on 10 ^th April 2013.

(2) This Order extends to England and Wales and Scotland.

Amendments to the Misuse of Drugs (Designation) Order 2001

2. In paragraph 1(a) of Part 1 of the Schedule to the Misuse of Drugs (Designation) Order 2001( 2 ) (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies) after “Cannabis” insert “(not being the substance specified in paragraph 4 of Part 2 of this Schedule)”.

3. After paragraph 3 of Part 2 of the Schedule to the Misuse of Drugs (Designation) Order 2001 (which specifies controlled drugs excepted from Part 1)( 3 ) insert—

“ 4. A liquid formulation—

(a) containing a botanical extract of cannabis—

(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and

(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,

(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and

(c) which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on 16 ^th June 2010 ( 4 ) ” .